Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMETEK INC/AME · Entity 3025 | Director | March 18, 2026 | March 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMETEK INC/
Report date March 18, 2026 · Filed March 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 30,298 |
Reported balance
After 2026-03-18 transaction · row 1
1 source rowRow 1 · 2026-03-18 · Grant · Acquired 950 · Balance 30,298 F1: Constitutes restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Constitutes restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
BIOTELEMETRY, INC.
Report date February 09, 2021 · Filed February 12, 2021
Section 16 reporting ended · disclosed 2021-02-12. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-02-09 transaction · row 1
1 source rowRow 1 · 2021-02-09 · Disposition to issuer · Disposed 104,507 · Balance 0 F1: Represents restricted stock units that, pursuant to the terms of the Agreement and Plan of Merger, dated as of December 18, 2020, among the Company, Philips Holding USA Inc., a Delaware corporation, and Davies Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), were cancelled at the Effective Time of the Merger (both as defined in the Merger Agreement) and converted into the right to receive $72.00 per share in cash, less any applicable withholding taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units that, pursuant to the terms of the Agreement and Plan of Merger, dated as of December 18, 2020, among the Company, Philips Holding USA Inc., a Delaware corporation, and Davies Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), were cancelled at the Effective Time of the Merger (both as defined in the Merger Agreement) and converted into the right to receive $72.00 per share in cash, less any applicable withholding taxes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 18, 2026 Filed Mar 18, 2026 21:20 UTC | AMETEK INC/ AME · Entity 3025 | GrantCommon Stock | 950 | $212.77 | $202,131.50 |
DisclosureSEC source: 0001037868-26-000079 · wk-form4_1773868828.xml · nonDerivative · entry 1 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,298 F1 · kind: Constitutes restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. Read SEC document |
| March 18, 2025 Filed Mar 18, 2025 21:05 UTC | AMETEK INC/ AME · Entity 3025 | GrantCommon Stock | 1,030 | $176.08 | $181,362.40 |
DisclosureSEC source: 0001127602-25-009816 · form4.xml · nonDerivative · entry 1 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,348 F1 · kind: Constitutes restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. Read SEC document |
| March 19, 2024 Filed Mar 20, 2024 20:08 UTC | AMETEK INC/ AME · Entity 3025 | GrantCommon Stock | 1,030 | $181.93 | $187,387.90 |
DisclosureSEC source: 0001127602-24-010762 · form4.xml · nonDerivative · entry 1 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,318 F1 · kind: Constitutes restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. Read SEC document |
| March 22, 2023 Filed Mar 23, 2023 13:01 UTC | AMETEK INC/ AME · Entity 3025 | GrantCommon Stock | 1,210 | $138.46 | $167,536.60 |
DisclosureSEC source: 0001127602-23-011086 · form4.xml · nonDerivative · entry 1 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,288 F1 · kind: Constitutes restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. Read SEC document |
| March 21, 2023 Filed Mar 22, 2023 20:11 UTC | AMETEK INC/ AME · Entity 3025 | Exercise / conversionStock Option · Derivative | 3,440 | $0.00 Strike: $46.96 | $0.00 |
DisclosureSEC source: 0001127602-23-011023 · form4.xml · derivative · entry 3 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,440 shares Expires 2023-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options will become exercisable in four equal annual installments beginning on May 4, 2017. Read SEC document |
| March 21, 2023 Filed Mar 22, 2023 20:11 UTC | AMETEK INC/ AME · Entity 3025 | SaleCommon Stock | 3,440 | $139.57 | $480,117.02 |
DisclosureSEC source: 0001127602-23-011023 · form4.xml · nonDerivative · entry 2 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,078 F1 · price: The shares were sold at prices ranging from $139.55 to $139.60. Upon request by the SEC staff the issuer or any security holder of the issuer, the reporting person will provide information regarding the number of shares sold at each separate price. Read SEC document |
| March 21, 2023 Filed Mar 22, 2023 20:11 UTC | AMETEK INC/ AME · Entity 3025 | Exercise / conversionCommon Stock | 3,440 | $46.96 | $161,542.40 |
DisclosureSEC source: 0001127602-23-011023 · form4.xml · nonDerivative · entry 1 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:01 UTC | AMETEK INC/ AME · Entity 3025 | Exercise / conversionStock Option · Derivative | 2,000 | $0.00 Strike: $46.96 | $0.00 |
DisclosureSEC source: 0001127602-23-009050 · form4.xml · derivative · entry 3 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,440 Underlying: Common Stock · 2,000 shares Expires 2023-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options will become exercisable in four equal annual installments beginning on May 4, 2017. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:01 UTC | AMETEK INC/ AME · Entity 3025 | SaleCommon Stock | 2,000 | $143.61 | $287,217.00 |
DisclosureSEC source: 0001127602-23-009050 · form4.xml · nonDerivative · entry 2 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,078 F1 · price: The shares were sold at prices ranging from $143.60 to $143.63. Upon request by the SEC staff the issuer or any security holder of the issuer, the reporting person will provide information regarding the number of shares sold at each separate price. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:01 UTC | AMETEK INC/ AME · Entity 3025 | Exercise / conversionCommon Stock | 2,000 | $46.96 | $93,920.00 |
DisclosureSEC source: 0001127602-23-009050 · form4.xml · nonDerivative · entry 1 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,078 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 25, 2022 Filed Mar 28, 2022 20:01 UTC | AMETEK INC/ AME · Entity 3025 | Exercise / conversionStock Option · Derivative | 5,160 | $0.00 Strike: $52.27 | $0.00 |
DisclosureSEC source: 0001127602-22-010446 · form4.xml · derivative · entry 3 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,160 shares Expires 2022-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options became exercisable in four equal annual installments beginning on May 6, 2016. Read SEC document |
| March 25, 2022 Filed Mar 28, 2022 20:01 UTC | AMETEK INC/ AME · Entity 3025 | SaleCommon Stock | 5,160 | $133.37 | $688,186.10 |
DisclosureSEC source: 0001127602-22-010446 · form4.xml · nonDerivative · entry 2 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,078 F1 · price: The shares were sold at prices ranging from $133.25 to $133.44. Upon request by the SEC staff the issuer or any security holder of the issuer, the reporting person will provide information regarding the number of shares sold at each separate price. Read SEC document |
| March 25, 2022 Filed Mar 28, 2022 20:01 UTC | AMETEK INC/ AME · Entity 3025 | Exercise / conversionCommon Stock | 5,160 | $52.27 | $269,713.20 |
DisclosureSEC source: 0001127602-22-010446 · form4.xml · nonDerivative · entry 1 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,238 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 21, 2022 Filed Mar 21, 2022 20:52 UTC | AMETEK INC/ AME · Entity 3025 | GrantCommon Stock | 1,280 | $134.69 | $172,403.20 |
DisclosureSEC source: 0001127602-22-010033 · form4.xml · nonDerivative · entry 1 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,078 F1 · kind: Constitutes restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. Read SEC document |
| March 25, 2021 Filed Mar 25, 2021 20:46 UTC | AMETEK INC/ AME · Entity 3025 | Exercise / conversionStock Option · Derivative | 740 | $0.00 Strike: $53.13 | $0.00 |
DisclosureSEC source: 0001127602-21-012029 · form4.xml · derivative · entry 3 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 740 shares Expires 2021-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options will become exercisable in four equal annual installments beginning on May 8, 2015. Read SEC document |
| March 25, 2021 Filed Mar 25, 2021 20:46 UTC | AMETEK INC/ AME · Entity 3025 | SaleCommon Stock | 740 | $121.43 | $89,858.27 |
DisclosureSEC source: 0001127602-21-012029 · form4.xml · nonDerivative · entry 2 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,798 Read SEC document |
| March 25, 2021 Filed Mar 25, 2021 20:46 UTC | AMETEK INC/ AME · Entity 3025 | Exercise / conversionCommon Stock | 740 | $53.13 | $39,316.20 |
DisclosureSEC source: 0001127602-21-012029 · form4.xml · nonDerivative · entry 1 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2021 Filed Mar 12, 2021 21:17 UTC | AMETEK INC/ AME · Entity 3025 | GrantCommon Stock | 1,280 | $121.91 | $156,044.80 |
DisclosureSEC source: 0001127602-21-010393 · form4.xml · nonDerivative · entry 1 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,798 F1 · shares: Constitutes restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. Read SEC document |
| February 09, 2021 Filed Feb 12, 2021 02:38 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | Disposition to issuerCommon Stock | 104,507 | $72.00 | $7,524,504.00 |
DisclosureSEC source: 0000899243-21-006153 · doc4.xml · nonDerivative · entry 1 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Represents restricted stock units that, pursuant to the terms of the Agreement and Plan of Merger, dated as of December 18, 2020, among the Company, Philips Holding USA Inc., a Delaware corporation, and Davies Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), were cancelled at the Effective Time of the Merger (both as defined in the Merger Agreement) and converted into the right to receive $72.00 per share in cash, less any applicable withholding taxes. Read SEC document |
| November 11, 2020 Filed Nov 12, 2020 21:09 UTC | AMETEK INC/ AME · Entity 3025 | Exercise / conversionStock Option · Derivative | 3,000 | $0.00 Strike: $53.13 | $0.00 |
DisclosureSEC source: 0001127602-20-028771 · form4.xml · derivative · entry 3 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 740 Underlying: Common Stock · 3,000 shares Expires 2021-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options will become exercisable in four equal annual installments beginning on May 8, 2015. Read SEC document |
| November 11, 2020 Filed Nov 12, 2020 21:09 UTC | AMETEK INC/ AME · Entity 3025 | SaleCommon Stock | 3,000 | $116.75 | $350,255.10 |
DisclosureSEC source: 0001127602-20-028771 · form4.xml · nonDerivative · entry 2 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,518 Read SEC document |
| November 11, 2020 Filed Nov 12, 2020 21:09 UTC | AMETEK INC/ AME · Entity 3025 | Exercise / conversionCommon Stock | 3,000 | $53.13 | $159,390.00 |
DisclosureSEC source: 0001127602-20-028771 · form4.xml · nonDerivative · entry 1 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:29 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | GrantCommon Stock | 2,863 | $0.00 | $0.00 |
DisclosureSEC source: 0001574774-20-000081 · wf-form4_158940537582411.xml · nonDerivative · entry 1 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,507 F1 · shares: Grant of restricted stock units that, subject to certain exceptions, will vest in full on the first anniversary of the grant date. Read SEC document |
| May 06, 2020 Filed May 6, 2020 21:46 UTC | AMETEK INC/ AME · Entity 3025 | Exercise / conversionStock Option · Derivative | 5,190 | $0.00 Strike: $41.74 | $0.00 |
DisclosureSEC source: 0001127602-20-015663 · form4.xml · derivative · entry 3 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,190 shares Expires 2020-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options will become exercisable in four equal annual installments beginning on May 8, 2014. Read SEC document |
| May 06, 2020 Filed May 6, 2020 21:46 UTC | AMETEK INC/ AME · Entity 3025 | SaleCommon Stock | 1,000 | $81.53 | $81,526.00 |
DisclosureSEC source: 0001127602-20-015663 · form4.xml · nonDerivative · entry 2 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,518 Read SEC document |
| May 06, 2020 Filed May 6, 2020 21:46 UTC | AMETEK INC/ AME · Entity 3025 | Exercise / conversionCommon Stock | 5,190 | $41.74 | $216,630.60 |
DisclosureSEC source: 0001127602-20-015663 · form4.xml · nonDerivative · entry 1 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2020 Filed Mar 20, 2020 22:56 UTC Amendment | AMETEK INC/ AME · Entity 3025 | GrantCommon Stock | 2,130 | $63.37 | $134,978.10 |
DisclosureSEC source: 0001127602-20-011678 · form4a.xml · nonDerivative · entry 1 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,328 F1 · kind: Constitutes restricted stock issued under the AMETEK, Inc. 2011 Omnibus Incentive Compensation Plan. F2 · price: On March 20, 2020, due to a clerical error, the reporting person filed a Form 4 with an incorrect price. This Form 4 amends the originally filed Form 4 to provide the correct price. F3 · balance_after: Balance has been updated to accurately reflect the transactions reported by the reporting person on Form 4 filed with the SEC on June 21, 2019. Read SEC document |
| March 20, 2020 Filed Mar 20, 2020 20:39 UTC | AMETEK INC/ AME · Entity 3025 | GrantCommon Stock | 2,130 | $72.95 | $155,385.63 |
DisclosureSEC source: 0001127602-20-011642 · form4.xml · nonDerivative · entry 1 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,328 F1 · kind: Constitutes restricted stock issued under the AMETEK, Inc. 2011 Omnibus Incentive Compensation Plan. F2 · balance_after: Balance has been updated to accurately reflect the transactions reported by the reporting person on Form 4 filed with the SEC on June 21, 2019. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 22:43 UTC | AMETEK INC/ AME · Entity 3025 | Exercise / conversionStock Option · Derivative | 1,570 | $0.00 Strike: $30.74 | $0.00 |
DisclosureSEC source: 0001127602-19-022544 · form4.xml · derivative · entry 3 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,570 shares Expires 2019-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options will become exercisable in four equal annual installments beginning on July 26, 2013. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 22:43 UTC | AMETEK INC/ AME · Entity 3025 | SaleCommon Stock | 1,570 | $87.79 | $137,834.85 |
DisclosureSEC source: 0001127602-19-022544 · form4.xml · nonDerivative · entry 2 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,628 F1 · price: The shares were sold at prices ranging from $87.7851 to $87.80. Upon request by the SEC staff, the issuer, or any security holder of the issuer, the reporting person will provide information regarding the number of shares sold at each separate price. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 22:43 UTC | AMETEK INC/ AME · Entity 3025 | Exercise / conversionCommon Stock | 1,570 | $30.74 | $48,261.80 |
DisclosureSEC source: 0001127602-19-022544 · form4.xml · nonDerivative · entry 1 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,198 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2019 Filed May 10, 2019 12:59 UTC | AMETEK INC/ AME · Entity 3025 | GrantCommon Stock | 1,860 | $85.45 | $158,937.00 |
DisclosureSEC source: 0001127602-19-018041 · form4.xml · nonDerivative · entry 1 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,198 F1 · kind: Constitutes restricted stock issued under the AMETEK, Inc. 2011 Omnibus Incentive Compensation Plan. Read SEC document |
| May 03, 2019 Filed May 7, 2019 22:15 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | GrantCommon Stock | 2,424 | $0.00 | $0.00 |
DisclosureSEC source: 0001574774-19-000047 · wf-form4_155726733230950.xml · nonDerivative · entry 1 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,644 F1 · shares: Grant of restricted stock units that, subject to certain exceptions, will vest in full on the first anniversary of the grant date. Read SEC document |
| March 12, 2019 Filed Mar 13, 2019 12:55 UTC | AMETEK INC/ AME · Entity 3025 | Exercise / conversionStock Option · Derivative | 4,725 | $0.00 Strike: $34.05 | $0.00 |
DisclosureSEC source: 0001127602-19-011130 · form4.xml · derivative · entry 3 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,725 shares Expires 2019-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options will become exercisable in four equal installments beginning on May 1, 2013. Read SEC document |
| March 12, 2019 Filed Mar 13, 2019 12:55 UTC | AMETEK INC/ AME · Entity 3025 | SaleCommon Stock | 4,725 | $80.17 | $378,807.03 |
DisclosureSEC source: 0001127602-19-011130 · form4.xml · nonDerivative · entry 2 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,338 F1 · price: The shares were sold at prices ranging from $80.1655 to $80.1855. Upon request by the SEC staff, the issuer, or any security holder of the issuer, the reporting person will provide information regarding the number of shares sold at each separate price. Read SEC document |
| March 12, 2019 Filed Mar 13, 2019 12:55 UTC | AMETEK INC/ AME · Entity 3025 | Exercise / conversionCommon Stock | 4,725 | $34.05 | $160,870.66 |
DisclosureSEC source: 0001127602-19-011130 · form4.xml · nonDerivative · entry 1 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 08, 2018 Filed May 9, 2018 20:48 UTC | AMETEK INC/ AME · Entity 3025 | GrantCommon Stock | 1,930 | $73.45 | $141,758.50 |
DisclosureSEC source: 0001127602-18-016762 · form4.xml · nonDerivative · entry 1 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,338 F1 · kind: Constitutes restricted stock issued under the AMETEK, Inc. 2011 Omnibus Incentive Compensation Plan. Read SEC document |
| May 04, 2018 Filed May 8, 2018 20:19 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | GrantCommon Stock | 3,191 | $0.00 | $0.00 |
DisclosureSEC source: 0001574774-18-000036 · wf-form4_152581074486715.xml · nonDerivative · entry 1 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,220 F1 · shares: Grant of restricted stock units that, subject to certain exceptions, will vest in full on the first anniversary of the grant date. Read SEC document |
| March 09, 2018 Filed Mar 12, 2018 20:10 UTC | AMETEK INC/ AME · Entity 3025 | Exercise / conversionStock Option · Derivative | 4,050 | $0.00 Strike: $29.83 | $0.00 |
DisclosureSEC source: 0001127602-18-011170 · form4.xml · derivative · entry 3 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,050 shares Expires 2018-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options will become exercisable in four equal installments beginning on May 3, 2012. Read SEC document |
| March 09, 2018 Filed Mar 12, 2018 20:10 UTC | AMETEK INC/ AME · Entity 3025 | SaleCommon Stock | 4,050 | $78.14 | $316,475.51 |
DisclosureSEC source: 0001127602-18-011170 · form4.xml · nonDerivative · entry 2 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,408 F1 · price: The shares were sold at prices ranging from $77.86 to $78.41. Upon request by the SEC staff, the issuer, or any security holder of the issuer, the reporting person will provide information regarding the number of shares sold at each separate price. Read SEC document |
| March 09, 2018 Filed Mar 12, 2018 20:10 UTC | AMETEK INC/ AME · Entity 3025 | Exercise / conversionCommon Stock | 4,050 | $29.83 | $120,798.14 |
DisclosureSEC source: 0001127602-18-011170 · form4.xml · nonDerivative · entry 1 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,458 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2017 Filed May 16, 2017 21:22 UTC | BIOTELEMETRY, INC. BEAT · Entity 142764 | GrantCommon Stock | 2,842 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-032808 · doc4.xml · nonDerivative · entry 1 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,029 F1 · shares: Represents shares of the Issuer's common stock underlying restricted stock units (RSUs) awarded to the Reporting Person. The RSUs shall vest annually following the award date. In the event of the occurrence of the Reporting Person's death, Disability (within the meaning of such term under section 409A(a)(2)(C) of the Internal Revenue Code of 1986, as amended (the "Code")), "separation from service" (within the meaning of such term under Code section 409A(a)(2)(A)(i)) or a 409A Change in Control Event (as defined in the award agreement) prior to the full vesting date, all outstanding RSUs shall be fully vested. The shares of common stock underlying the RSUs will be issued when the RSUs vest. F2 · balance_after: Includes 2,842 shares of the Issuer's common stock subject to the reported RSU award. Read SEC document |
| May 09, 2017 Filed May 11, 2017 19:01 UTC | AMETEK INC/ AME · Entity 3025 | GrantCommon Stock | 3,040 | $60.30 | $183,312.00 |
DisclosureSEC source: 0001127602-17-017690 · form4.xml · nonDerivative · entry 1 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,408 F1 · kind: Constitutes restricted stock issued under the AMETEK, Inc. 2011 Omnibus Incentive Compensation Plan. Read SEC document |
| May 05, 2017 Filed May 5, 2017 20:10 UTC | AMETEK INC/ AME · Entity 3025 | Exercise / conversionStock Option · Derivative | 4,756 | $0.00 Strike: $19.62 | $0.00 |
DisclosureSEC source: 0001127602-17-017067 · form4.xml · derivative · entry 3 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,756 shares Expires 2017-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options will become exercisable in four equal annual installments beginning on July 29, 2011. Read SEC document |
| May 05, 2017 Filed May 5, 2017 20:10 UTC | AMETEK INC/ AME · Entity 3025 | SaleCommon Stock | 4,756 | $60.42 | $287,357.52 |
DisclosureSEC source: 0001127602-17-017067 · form4.xml · nonDerivative · entry 2 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,368 Read SEC document |
| May 05, 2017 Filed May 5, 2017 20:10 UTC | AMETEK INC/ AME · Entity 3025 | Exercise / conversionCommon Stock | 4,756 | $19.62 | $93,323.18 |
DisclosureSEC source: 0001127602-17-017067 · form4.xml · nonDerivative · entry 1 Conti Anthony James · CIK 0001496776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,124 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.